The Asthma and Allergy Foundation of America is warning asthmatics and the public not to inhale hydrogen peroxide through a nebulizer to treat or prevent COVID-19. The AAFA said the practice has been circulated on social media as a home remedy.
A clinical trial of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo.Read More
Individuals with asthma who live in redlined neighborhoods have worse lung function than those in locales that excluded Black people.Read More
One-in-eight (13%) e-cigarette users had asthma and those with asthma had nearly 24% increased odds of having an asthma attack within 12 months.Read More
A five-year trial found at least 75% of Fasenra-treated asthma patients with elevated blood eosinophil levels had zero exacerbations each year of the open-label period.Read More
A national clinical research network called Childhood Asthma in Urban Settings (CAUSE) will conduct observational studies and clinical trials to develop treatment and prevention approaches tailored to children of low-income families living in urban communities.Read More
A hospital in Israel says COVID-19 related mask wearing helped reduce severe asthma cases requiring hospitalization by 65%.Read More
The US FDA has approved Genetech’s Xolair (omalizumab) prefilled syringe for self-injection for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria, and nasal polyps.Read More